glp 1 drugs heart failure GLP-1 Receptor Agonists in Potential Mechanisms of the Protective

S3)):S434S442

202 A Phase 2a study of efocipegtrutide (HM15211), a new long-acting triple GLP-1/GIP/glucagon RA is currently being conducted to assess its use to treat non-alcoholic steatohepatitis

Even when using intermittent fasting, individuals taking GLP-1s should be encouraged to consume meals at regular times of the day

Liraglutide attenuates the osteoblastic differentiation of MC3T3-E1 cells by modulating AMPK/mTOR signaling

R., Holscher C

Des tudes ont montr que les signaux en aval rsultant de la liaison entre lorforglipron ou le GLP-1 dune part et le rcepteur au GLP-1 dautre part sont similaires mais distincts